NuVim, Innovative Technologies merge
This article was originally published in The Tan Sheet
Executive SummaryParamus, N.J.-based nutritional firm NuVim signed a letter of intent to merge with supplement firm Innovative Technologies Corporation of America, NuVim says Aug. 20. Combined, annual gross revenues total approximately $5 million and under the terms, NuVim will have sales and distribution rights to market ITCA's hangover product Hair of the Dog worldwide. NuVim will "issue debt to finance the cash portion of the merger" and once completed, the merger will operate under the name NuVim. Tampa-based ITCA will receive $2.3 million cash and 4.25 million shares of "restricted common stock in the tax free reorganization," firm says
You may also be interested in...
The Committee on Energy and Commerce of the US House of Representatives has requested a set of documents from the FDA in order to assess whether the agency is doing enough to address the challenge of approving complex generics within its existing authorities, or whether additional authority is needed.
As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.